e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Notable abstracts in COPD: variety
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Morning and nighttime symptoms in COPD and efficacy of aclidinium/formoterol in symptomatic vs asymptomatic patients
Marc Miravitlles (Barcelona, Spain), Marc Miravitlles, Esther Garcia Gil, Ferran Chuecos, Rosa Lamarca
Source:
International Congress 2015 – Notable abstracts in COPD: variety
Session:
Notable abstracts in COPD: variety
Session type:
Oral Presentation
Number:
1968
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marc Miravitlles (Barcelona, Spain), Marc Miravitlles, Esther Garcia Gil, Ferran Chuecos, Rosa Lamarca. Morning and nighttime symptoms in COPD and efficacy of aclidinium/formoterol in symptomatic vs asymptomatic patients. Eur Respir J 2015; 46: Suppl. 59, 1968
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
QVA149 reduces COPD exacerbation rate in various subgroups of patients: The SPARK study
Source: Annual Congress 2013 –New bronchodilators for COPD management
Year: 2013
Baseline symptom scores and future risk of severe exacerbation: The SPARK study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Repercussion of cough in sleep quality in COPD exacerbation
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014
Effect of glycopyrronium vs tiotropium on pulmonary function and morning symptoms in patients with moderate-to-severe COPD: The SPRING study
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015
Do patients with asthma cough more frequently at night during impedance/pH monitoring than other patients with chronic cough?
Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Year: 2019
Once-daily QVA149 improves symptom scores in patients with COPD
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Assessing COPD profiles and outcomes by dyspnoea severity
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Are COPD patients with chronic dyspnea and attending pulmonary rehabilitation treated with dual bronchodilatation or not?
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Roflumilast added to triple therapy in severe COPD patients with frequent exacerbations: Efficacy and tolerability
Source: International Congress 2014 – Markers
Year: 2014
PAP therapy impact on COPD exacerbations rate in patients with overlap syndrome
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015
COPD on anti-GERD therapy remains at higher risk for severe exacerbation
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Usefulness of severity predictive scores in COPD exacerbations in hospitalized patients
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
COPD patients may suffer from frequent exacerbations but mostly do not - Subpopulations of a real life survey in more than 1.700 patients
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Once-daily glycopyrronium improves lung function and reduces exacerbations in severe-to-very severe COPD patients: The SPARK study
Source: Annual Congress 2013 –New bronchodilators for COPD management
Year: 2013
QVA149 improves lung function and reduces exacerbations compared to tiotropium in patients with severe-to-very severe COPD: The SPARK study
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Impact of nighttime and early morning symptoms on HRQoL and work productivity of COPD patients
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
QVA149 provides significant symptomatic benefit to COPD patients as measured by a new symptom e-diary: The SHINE study
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Impact of pulmonary rehabilitation on cough and sputum symptom perception in patients with COPD
Source: International Congress 2015 – Latest insights into pulmonary rehabilitation
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept